日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Presentation of hemagglutinin on adjuvant-bearing self-assembling peptide nanofibers increases heterologous responses against influenza

在佐剂负载的自组装肽纳米纤维上呈递血凝素可增强针对流感的异源免疫反应

Roe, Emily F; Votaw, Nicole L; Lazar, Kat M; Burke, Kaitlyn N; Miranda, Hector A; Fries, Chelsea N; Rock, Michelle L; Macintyre, Andrew N; Stover, Erica L; Huskey, Jessica B; Harris, Summer J; Landon, Chelsea D; Mansouri, Katayoun; Edwards, Robert J; Heaton, Nicholas S; Collier, Joel H

FUT1- and GAL3ST2-mediated cellular glycan remodeling broadly restricts sialic acid-dependent viral infections

FUT1 和 GAL3ST2 介导的细胞聚糖重塑广泛限制了唾液酸依赖性病毒感染。

Zhu, Xinyu; Nakano, Satoko; Rao, Vishwas N; Miranda, Hector A; Spurrier, M Ariel; Skavicus, Samantha; Luo, Zhaochen; Heaton, Nicholas S

The Shigella flexneri effector IpaH1.4 facilitates RNF213 degradation and protects cytosolic bacteria against interferon-induced ubiquitylation.

福氏志贺氏菌效应蛋白 IpaH1.4 促进 RNF213 降解,并保护胞质细菌免受干扰素诱导的泛素化作用。

Saavedra-Sanchez Luz, Dickinson Mary S, Apte Shruti S, Zhang Yifeng, De Jong Maarten, Skavicus Samantha, Heaton Nicholas S, Alto Neal M, Coers Jorn

Administration of antigenically distinct influenza viral particle combinations as an influenza vaccine strategy.

将抗原性不同的流感病毒颗粒组合作为流感疫苗策略

Zhu Xinyu, Luo Zhaochen, Leonard Rebecca A, Hamele Cait E, Spreng Rachel L, Heaton Nicholas S

Development of DNA and mRNA-LNP vaccines against an H5N1 clade 2.3.4.4b influenza virus.

针对 H5N1 2.3.4.4b 分支流感病毒的 DNA 和 mRNA-LNP 疫苗的开发

Leonard Rebecca A, Spurrier M Ariel, Skavicus Samantha, Luo Zhaochen, Heaton Brook E, Spreng Rachel L, Hong Jiaqi, Yuan Fan, Heaton Nicholas S

Species-specific chromatin architecture and neurogenesis mediated by a human enhancer

人类增强子介导的物种特异性染色质结构和神经发生

Mosti, Federica; Liu, Jing; Lam, Katie; Skavicus, Samantha; Kapps, Victoria A; Gjoni, Ketrin; Heaton, Nicholas S; Pollard, Katherine S; Silver, Debra L

Vaccination with antigenically complex hemagglutinin mixtures confers broad protection from influenza disease.

接种含有复杂抗原的血凝素混合物可对流感提供广泛的保护

Luo Zhaochen, Miranda Hector A, Burke Kaitlyn N, Spurrier M Ariel, Berry Madison, Stover Erica L, Spreng Rachel L, Waitt Greg, Soderblom Erik J, Macintyre Andrew N, Wiehe Kevin, Heaton Nicholas S

Headless hemagglutinin-containing influenza viral particles direct immune responses toward more conserved epitopes.

不含血凝素的流感病毒颗粒会将免疫反应引导至更保守的表位

Hamele Cait E, Luo Zhaochen, Leonard Rebecca A, Spurrier M Ariel, Burke Kaitlyn N, Webb Stacy R, Rountree Wes, Li Zongli, Heaton Brook E, Heaton Nicholas S

Fluorescent and bioluminescent bovine H5N1 influenza viruses for evaluation of antiviral interventions.

用于评估抗病毒干预措施的荧光和生物发光牛H5N1流感病毒

Trimarco Joseph D, Spurrier M Ariel, Skavicus Samantha, Luo Zhaochen, Dutta Moumita, Janowska Katarzyna, Acharya Priyamvada, Heaton Brook E, Heaton Nicholas S

A low-background, fluorescent assay to evaluate inhibitors of diverse viral proteases

低背景荧光检测法用于评估多种病毒蛋白酶抑制剂

Rebecca A Leonard, Vishwas N Rao, Alexandria Bartlett, Heather M Froggatt, Micah A Luftig, Brook E Heaton, Nicholas S Heaton